SCM
TVGN icon

Sterling Capital Management’s Tevogen Bio Holdings TVGN Stock Holding History

Sterling Capital Management’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$90 Hold
20
– – ﹤0.01% 3201
2025
Q4 		$336 Buy
20
+1
+5% +$26 ﹤0.01% 3212
2025
Q3 		$743 Buy
19
+15
+375% +$738 ﹤0.01% 3121
2025
Q2 		$258 Hold
4
– – ﹤0.01% 3218
2025
Q1 		$203 Buy
4
+3
+300% +$197 ﹤0.01% 3082
2024
Q4 		$45 Hold
1
– – ﹤0.01% 3215
2024
Q3 		$16 Buy
+1
New +$29 ﹤0.01% 3255

Other funds holding TVGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Sterling Capital Management's TVGN Position: Q1 2026 in Review

Sterling Capital Management held its Tevogen Bio Holdings (TVGN) position steady in Q1 2026 at 20 shares worth $90. The position accounts for ﹤0.01% of the portfolio, ranked #3201.

Sterling Capital Management first reported a position in TVGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $743 in Q3 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • Sterling Capital Management held 20 shares of Tevogen Bio Holdings worth $90 as of Q1 2026.
  • Sterling Capital Management left its Tevogen Bio Holdings share count unchanged in Q1 2026.
  • Tevogen Bio Holdings made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #3201 holding.
  • Sterling Capital Management first reported a position in Tevogen Bio Holdings in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Tevogen Bio Holdings position peaked at $743 in Q3 2025.
  • 30 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.